Clinical Trial: Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07221370) titled 'Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients' on Nov. 08, 2024.

Brief Summary: The goal of this clinical trial is to determine if oral vancomycin can prevent C.diff infection in adults who are critically ill and are at high risk of C.diff infection due to their medical conditions and being in the hospital. It will also help us learn about the safety of the drug in this setting. The main questions the trial aims to answer are:

* Does oral vancomycin lower the rate of C.diff infection in high-risk patients?

* Does C.diff carrier status change the C.diff infection rat...